Iron Deficiency is an Ominous Predictor of Mortality in Elderly Patients with Stable Heart Failure: a Community Based Study
Journal Title: Cardiology and Angiology: An International Journal - Year 2014, Vol 2, Issue 4
Abstract
Background: Iron deficiency (ID) has been shown to be linked with poor outcomes within heart failure (HF) populations in previous clinical trials. The impact of ID has not been evaluated in stable chronic heart failure (HF) patients in the community. Our objective was to study the role of ID in stable HF patients and its impact on short term survival. Methods: In this study we analysed 512 patients with stable HF under the care of a regional nurse-led community heart failure team. The study started in June 2007 and ended in June 2010. Results: There were 92% of patients on loop diuretics; 83% on ACE Inhibitors, 92% on -blockers and 48% on aldosterone antagonists. Mean age of the patients was 77.9 years, 43% were females and mean NYHA class was 2.2. Absolute Iron deficiency (ID) and anemia were defined as ferritin <100µg/L and hemoglobin (Hb)<12g/dl, respectively. Mean Hb levels were 14.1; 13.9; 14.0 and 13.7g/dL at 0, 6, 12 and 24 months. Mean serum ferritin levels in the entire study population were 212µg/L at the start, and 197µg/L at the end. The prevalence of ID and anemia was 21.3% and 9.4%at the start, and was 21.5% and 8.4% at the end of the study. The prevalence of ID was 63%vs. 19% in subjects with vs. without anemia [p<0.001]. Risk-adjusted hazard ratios for 24-month mortality were 1.42 (95% confidence interval: 1.09-1.98) for ID and 1.05 (95% confidence interval; 0.87-1.51) for anemic patients respectively. Conclusions: In our study, ID was prevalent in stable HF patients in the community and was linked with poor clinical outcomes. In addition, ID was a predictor for mortality than additionally to anemia.
Authors and Affiliations
S. Ghosh, W. T. M. Robertson, C. Zhang, J. Smith, N. I. O’Kelly
Keywords
Related Articles
- EP ID EP344139
- DOI 10.9734/CA/2014/9811
- Views 59
- Downloads 0
Clinical Factors Associated with Atrial Fibrillation in Congestive Heart Failure Patients Admitted to the University Teaching Hospital, Lusaka, Zambia
Introduction: Atrial fibrillation (AF) and Congestive Heart failure (CHF) have emerged as major global epidemics. Each of these conditions predisposes to the other, and their concomitant presence has additive adverse eff...
No Synergic Effect of Sildenafil Administration on Exercise Capacity Improvement in a Fontan Patient with Regular Exercise Training
In Fontan patients, reduced exercise capacity due to diminished cardiac output is a common finding with important prognostic implications. Beneficial effects have been shown for sildenafil treatment and regular exercise,...
Effect of an Increase in Global Left Ventricular Afterload on Myocardial Deformation in Patients with Aortic Stenosis, Comparison with Hypertensive Patients
Aims: Left ventricular hypertrophy (LVH) secondary to hypertension and aortic stenosis (AS) are often considered together to be pressure overload hypertrophy. We hypothesized that important differences could e...
Statin Therapy in Patients with Type 2 Diabetes Mellitus in Hungary
Aim: The benefit of statin administration in the secondary prevention of cardiovascular diseases in type 2 diabetes mellitus (T2DM) is well documented. The aim of the study was to evaluate the characteristics of lipid lo...
Kunyima Relations Establishment on SS Sickle Cell Anaemia Women Investigation in Democratic Republic of Congo
Background: The sickle cell anaemia is a genetics sickness, autosomal, recessive, secondary to a punctual mutation at sixth codon level of β globine gene with substitution of glutamic acid by valine. The prevalence of S...